Amino Acid Infusion Before Cardiac Surgery Reduced Acute Kidney Injury
The amino acid mixture reduced stage 3 AKI by 44% compared with placebo
Source: medpagetoday.com
Improving Global Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Improving Global Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Improving Global Outcomes Today - Breaking & Trending Today
Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress
STOCKHOLM, May 28, 2024 /PRNewswire/ -- Calliditas Therapeutics AB , today announced the presentations of an additional efficacy analysis of Nefecon delayed release capsules)) as well as a...
Source: marketscreener.com
Semaglutide Significantly Improves Chronic Kidney Disease
The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD.
Source: medscape.com
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...
Source: prnewswire.com
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1%...
Source: prnewswire.com